Investigating significant health trends in growth hormone treatments registry: rationale, aims and design of a nationwide prospective registry (study protocol)

BACKGROUND: Somatropin treatment is indicated in a variety of disorders including growth hormone (GH) deficiency, Prader–Willi and Turner syndrome, chronic renal insufficiency and others. To date, almost all studies have been limited to single GH products, and no independent registry across indicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnabel, Dirk, Kreitschmann-Andermahr, Ilonka, Strasburger, Christian J., Pittrow, David, Pausch, Christine, Woelfle, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173596/
https://www.ncbi.nlm.nih.gov/pubmed/37165422
http://dx.doi.org/10.1186/s13023-023-02716-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173596/
https://www.ncbi.nlm.nih.gov/pubmed/37165422
http://dx.doi.org/10.1186/s13023-023-02716-3

Ejemplares similares